Urethroplasty for Female Urethral Stricture during the COVID-19 Pandemic: A Challenging Clinical Experience

Amidst the COVID-19 pandemic, managing female urethral strictures posed distinct challenges. Scar tissue development within the urethral sub-epithelial tissue led to constriction, causing lower urinary tract symptoms. Traditionally, urethral dilation was employed, but high recurrence rates prompted a shift towards formal urethroplasty. We observed 36 patients during this pandemic, gathering data on stricture management. Those with Q max >10 ml/sec underwent conservative measures; Q max <10 ml/sec cases received urethroplasty with vaginal mucosal grafts. The pandemic's impact on healthcare necessitated cautious surgical planning, while strict protocols ensured patient and staff safety. Prompt intervention remains vital for improved outcomes in female urethral stricture cases.